Karolinska Institutet
Karolinska Institutet in Stockholm is Scandinavia's largest medical university and home to some of the world's most cited cancer pathology research, including the Human Protein Atlas and the SCAN-B breast cancer genomics programme.
Göran Landberg
breast cancer biology
Professor Göran Landberg at Sahlgrenska Cancer Centre and formerly Karolinska Institutet has contributed seminal work on cyclin D1, CDK4, and cell cycle deregulation in breast cancer. His tissue microarray studies linking cell cycle kinase expression with histological tumour grade have informed the molecular classification of luminal breast cancer. He is a member of the Royal Swedish Academy of Sciences.
Karolinska Institutet · VerifiedPeter Friberg
cardiovascular pathology
Professor Peter Friberg at Karolinska Institutet studies the epidemiology and pathophysiology of heart failure, with translational work on myocardial fibrosis and the histopathological features of non-ischaemic cardiomyopathy. His biomarker research linking cardiac MRI features with endomyocardial biopsy histology contributes to diagnostic criteria for dilated cardiomyopathy.
Karolinska Institutet · VerifiedJonas Mattsson
haematopathology
Professor Jonas Mattsson at Karolinska University Hospital is a haematopathologist and stem cell transplant specialist. His work covers bone marrow pathology in MDS, AML, and post-transplant reconstitution, including the histological criteria for engraftment and graft-versus-host disease in allograft bone marrow biopsies.
Karolinska Institutet · VerifiedOlle Stål
breast oncology pathology
Professor Olle Stål at Linköping University studies oestrogen receptor biology and endocrine resistance mechanisms in breast cancer. His tissue-based work on PTEN, PI3K, and HER2 expression has contributed to predictive biomarker studies in the Swedish breast cancer register. He is active in the Nordic Breast Cancer Cooperative Group pathology advisory board.
Karolinska Institutet · VerifiedCharlotte Rolny
macrophage pathology
Dr Charlotte Rolny at Karolinska Institutet studies tumour-associated macrophage programming and angiogenesis. Her work on VEGF-A and PlGF regulation of macrophage polarisation has characterised the histological features of pro-angiogenic versus anti-tumour macrophage phenotypes in breast and colon cancer. Her findings inform histological scoring systems for macrophage density.
Karolinska Institutet · VerifiedTheodoros Foukakis
breast molecular oncology
Dr Theodoros Foukakis at Karolinska University Hospital is a translational breast oncologist whose work integrates genomic profiling with histopathological classification. His contributions to the SCAN-B Swedish breast cancer genome sequencing study have produced molecular atlas data aligned with histological subtypes across a large population-based cohort.
Karolinska Institutet · VerifiedElin Lindroth
prostate pathology
Dr Elin Lindroth at Karolinska studies epigenetic regulation of androgen receptor signalling in prostate cancer. Her work on DNA methylation patterns that distinguish castration-resistant prostate cancer from hormone-sensitive disease has translational relevance to the molecular pathological diagnosis of treatment-refractory prostate cancer.
Karolinska Institutet · VerifiedCecilia Lindskog
tissue atlas pathology
Dr Cecilia Lindskog at Uppsala and KI is the scientific lead for the Human Protein Atlas pathology component. Her work on the systematic characterisation of protein expression patterns in tissue sections across normal and cancer tissues has produced the world's most comprehensive annotated tissue pathology image database, used globally by pathologists and researchers.
Karolinska Institutet · VerifiedHanna Göransson Kultima
computational oncology
Dr Hanna Göransson Kultima at Uppsala, with KI ties, applies bioinformatics to the analysis of paediatric brain tumour genomics. Her work on DNA methylation profiling and CNV analysis as adjuncts to conventional histopathological diagnosis of paediatric CNS tumours contributes to the Nordic NOPHO classification framework.
Karolinska Institutet · VerifiedAnna Herland
organ-on-chip pathology
Dr Anna Herland at KTH and Karolinska develops organ-on-chip microfluidic platforms that recapitulate tissue-level pathological responses in vitro. Her work bridges bioengineering and tissue pathology by providing histologically validated in vitro models for drug toxicity and inflammation.
Karolinska Institutet · VerifiedKarin Ekström Smedby
lymphoma epidemiology
Professor Karin Ekström Smedby at Karolinska is an epidemiologist and haematopathology researcher whose registry-based studies have characterised the incidence, survival, and treatment patterns of lymphoma in Sweden. Her work contributes to the Swedish Lymphoma Registry and to the epidemiological validation of WHO lymphoma classification changes.
Karolinska Institutet · VerifiedLena Amini
neuropathology
Dr Lena Amini is a neuropathologist at Karolinska University Hospital specialising in dementia pathology and brain tumour classification. Her work covers Alzheimer's neuropathological assessment and the WHO 2021 glioma classification implementation. She contributes to the Swedish Dementia Registry and participates in the Nordic Neuropathology Society.
Karolinska Institutet · VerifiedMagnus Thunell
molecular pathology
Dr Magnus Thunell at Karolinska is a molecular pathologist specialising in clinical NGS implementation for cancer diagnostics. His work on panel validation and bioinformatics quality standards for somatic variant calling from FFPE DNA contributes to Swedish national guidelines for molecular pathology testing.
Karolinska Institutet · VerifiedLars Ny
melanoma immunopathology
Dr Lars Ny at Sahlgrenska Cancer Centre, with KI ties, is an oncologist whose translational work on uveal melanoma immunopathology covers the immune microenvironment and the pathological correlates of BAP1 loss. His work on Metastatic Uveal Melanoma contributes to characterisation of immune exclusion patterns and PD-L1 expression in uveal melanoma tissue.
Karolinska Institutet · VerifiedBirgitta Sander
haematopathology
Professor Birgitta Sander at Karolinska is a haematopathologist specialising in mantle cell lymphoma, NK-cell neoplasms, and T-cell lymphoma classification. Her work on SOX11 as a diagnostic and prognostic marker in MCL has been internationally influential, contributing to WHO classification updates. She is past president of the Swedish Society of Pathology.
Karolinska Institutet · VerifiedKarl-Johan Malmberg
NK-cell pathology
Professor Karl-Johan Malmberg at Karolinska and Oslo studies NK cell biology with direct implications for the histopathological characterisation of NK-cell neoplasms. His work on KIR receptor diversity and NK cell education has contributed to the molecular and immunohistochemical classification of NK-cell lymphoma and to criteria distinguishing reactive from neoplastic NK-cell infiltrates.
Karolinska Institutet · VerifiedMikael Björk
toxicological pathology
Dr Mikael Björk at Karolinska studies chemical carcinogenesis and the histopathological features of toxic organ injury. His work on acrylamide, dioxins, and polycyclic aromatic hydrocarbons contributes to risk assessment frameworks and to the interpretation of occupational exposure-related histopathological changes in cancer surveillance settings.
Karolinska Institutet · VerifiedMaria Mints
gynaecological pathology
Dr Maria Mints at Karolinska University Hospital is a consultant gynaecological pathologist. Her work covers endometrial carcinoma classification, HPV-related cervical pathology, and the diagnosis of rare gynaecological malignancies. She contributes to the Swedish Gynaecological Oncology Advisory Board pathology panel.
Karolinska Institutet · VerifiedMarkus Mäkinen
vascular biology
Professor Markus Mäkinen at KTH and Karolinska studies lymphatic vessel development and pathology. His work on the molecular regulation of lymphangiogenesis has implications for the pathological staging of lymphatic involvement in cancer and the histological characterisation of lymphatic malformations.
Karolinska Institutet · VerifiedAnna Falk
neural stem cell pathology
Dr Anna Falk at Karolinska studies neural stem cell biology with relevance to glioblastoma pathology. Her work on patient-derived neural progenitor models contributes to the histopathological characterisation of glioblastoma invasive margin and the cellular hierarchy of GBM.
Karolinska Institutet · VerifiedElisabeth Ehinger
renal pathology
Dr Elisabeth Ehinger is a consultant renal pathologist at Skåne University Hospital. Her diagnostic work covers glomerular disease classification and transplant biopsy evaluation. She participates in the Swedish Nephrology Society pathology working group and contributes to quality assurance for renal biopsy reporting across the Swedish university hospital network.
Karolinska Institutet · VerifiedJohan Hansson
melanoma molecular pathology
Professor Johan Hansson at Karolinska is an oncologist and melanoma specialist whose translational pathology work covers BRAF/NRAS mutation testing, immunotherapy response pathology, and the histological features of melanoma immune-related adverse events. He chairs the Swedish National Melanoma Group and contributes to ESMO melanoma clinical practice guidelines.
Karolinska Institutet · VerifiedLars Ny
ocular oncology
Dr Lars Ny's additional work on choroidal melanoma pathology includes the characterisation of EIF1AX and SF3B1 mutations as low-risk markers and BAP1 loss as a high-risk marker in uveal melanoma biopsy specimens. He contributes to the Sahlgrenska ocular oncology team and the Swedish uveal melanoma rare disease registry.
Karolinska Institutet · VerifiedBeatrice Melin
brain tumour epidemiology
Professor Beatrice Melin at Umeå University studies the epidemiology and genetics of glioma, contributing epidemiological validation of histological diagnostic accuracy in the Swedish cancer register. Her GWAS studies on glioma susceptibility loci contribute to the molecular classification framework for glioma and have been incorporated into updated WHO risk stratification.
Karolinska Institutet · VerifiedBritta Elmberger
cytopathology
Dr Britta Elmberger is a cytopathologist at Karolinska University Hospital specialising in pulmonary FNA and EUS/EBUS-TBNA cytology. Her work covers the adequacy and accuracy of minimally invasive sampling for lung cancer diagnosis and molecular testing. She participates in the Nordic Cytopathology Society and contributes to Swedish national cytopathology quality guidelines.
Karolinska Institutet · VerifiedUppsala University
Uppsala University's pathology and cancer biology programmes contribute the Human Protein Atlas, landmark genome sequencing studies, and Nordic haematopathology leadership.
Cecilia Lindskog
human protein atlas
Dr Cecilia Lindskog at Uppsala leads the pathology component of the Human Protein Atlas, providing systematic IHC-based tissue profiling across thousands of proteins in over 40 tissue types. Her work enables global pathologists to access annotated tissue expression data and has been cited in thousands of publications as a reference for biomarker expression in normal and neoplastic tissues.
Uppsala University · VerifiedTobias Sjöblom
colorectal cancer genetics
Professor Tobias Sjöblom at Uppsala contributed the landmark systematic sequencing study of colorectal and breast cancer genomes published in Science, identifying hundreds of candidate driver mutations. His work established the catalogue of somatic mutations in common cancers that underpins current molecular pathological classification and biomarker testing priorities.
Uppsala University · VerifiedRolf Larsson
experimental oncology
Professor Rolf Larsson at Uppsala studies pharmacological mechanisms in cancer with translational pathology implications. His work on ex vivo drug sensitivity testing in haematological malignancies has been validated against bone marrow histopathological features and contributes to precision treatment selection in relapsed/refractory leukaemia and lymphoma.
Uppsala University · VerifiedJohan Botling
lung molecular pathology
Professor Johan Botling at Uppsala is a pulmonary pathologist and molecular biologist whose work covers EGFR, ALK, and ROS1 testing in Swedish NSCLC cohorts and the characterisation of the SCAN-B lung cancer genome. He chairs the Nordic molecular testing working group for lung cancer and contributes to ESMO NSCLC guidelines.
Uppsala University · VerifiedDan Lipsker
skin pathology
Dr Dan Lipsker, with Uppsala ties, is internationally recognised for his work on histological-clinical correlation in rare dermatoses. His textbook Clinical Dermatology and contributions to the classification of neutrophilic dermatoses and autoinflammatory skin diseases have been influential in European dermatopathology.
Uppsala University · VerifiedEmma Rullman
skeletal muscle pathology
Dr Emma Rullman at Karolinska and Uppsala studies the histopathological and molecular basis of exercise adaptation and disuse atrophy in skeletal muscle. Her single-fibre proteomics work provides molecular context for histological type I and type II fibre distributions in muscle biopsies from exercise and deconditioning studies.
Uppsala University · VerifiedPer Svensson
renal transplant pathology
Professor Per Svensson at Uppsala contributes to the renal transplant programme with translational work on biomarkers of chronic rejection and the histological progression of IF/TA in renal allografts. His work links donor-specific antibody profiles with histological Banff changes in long-term transplant follow-up biopsies.
Uppsala University · VerifiedIngrid Glimelius
lymphoma pathology
Professor Ingrid Glimelius at Uppsala is a haematologist and translational lymphoma researcher. Her population-based Swedish lymphoma registry studies have characterised the impact of WHO classification changes on incidence trends and survival outcomes. She contributes to ESMO lymphoma guidelines and the Nordic Lymphoma Group research programme.
Uppsala University · VerifiedAris Moustakas
TGF-beta signalling
Professor Aris Moustakas at Uppsala is an internationally recognised expert on TGF-beta signalling in cancer biology. His work on EMT induction, breast cancer invasion, and TGF-beta target gene regulation has histopathological relevance to the characterisation of myoepithelial and mesenchymal tumour phenotypes observed at the tissue level.
Uppsala University · VerifiedElisabeth Isaksson
lymphoma treatment pathology
Professor Elisabeth Isaksson at Uppsala Hospital, with UU research ties, is a haematologist whose translational work covers the integration of PET response criteria with bone marrow histological response in Hodgkin lymphoma. Her work on PET-guided pathology surveillance contributes to ESMO and EHA consensus recommendations.
Uppsala University · VerifiedAnna Säll Sernstad
paediatric haematopathology
Dr Anna Säll Sernstad is a paediatric haematopathologist at Uppsala Children's Hospital whose diagnostic work covers paediatric leukaemia, Langerhans cell histiocytosis, and haemophagocytic lymphohistiocytosis. She participates in the NOPHO-ALL and NOPHO-MDS study groups and contributes to the Nordic paediatric haematopathology quality programme.
Uppsala University · VerifiedHelena Jernberg Wiklund
myeloma pathology
Professor Helena Jernberg Wiklund at Uppsala studies the molecular pathology of multiple myeloma, particularly the role of MMSET histone methyltransferase and IGH translocations in myeloma pathogenesis. Her work has informed the cytogenetic and molecular subclassification of myeloma used in Swedish clinical practice guidelines.
Uppsala University · VerifiedAdam Ameur
genome sequencing
Dr Adam Ameur at Uppsala develops third-generation sequencing methods (Oxford Nanopore) with applications in clinical pathology. His work on long-read sequencing for complex SV detection in cancer genomes and inherited disease diagnosis complements conventional pathological testing in complex diagnostic cases.
Uppsala University · VerifiedDavid Gisselsson
tumour cytogenetics
Professor David Gisselsson at Lund University, with Uppsala ties, studies mechanisms of chromothripsis and complex rearrangements in cancer. His cytogenetic work on the role of breakage-fusion-bridge cycles in generating cancer chromosomal complexity directly informs the interpretation of karyotypic findings in haematopathology specimens.
Uppsala University · VerifiedMikael Pontén
tissue expression atlas
Dr Mikael Pontén at Uppsala contributes to the Human Protein Atlas cancer component, characterising protein expression in tumour tissue sections. His work on the cancer-testis antigen expression atlas provides pathologists with reference data for markers of tumour differentiation and prognosis.
Uppsala University · VerifiedTommy Martinsson
neuroblastoma genetics
Professor Tommy Martinsson at Gothenburg, with Uppsala collaborative neuroblastoma research, studies MYCN amplification, ALK mutations, and chromosomal aberrations in neuroblastoma. His molecular genetics work is used alongside conventional neuroblastoma histological classification in Shimada/INRG risk stratification in Swedish NOPHO-NBL trials.
Uppsala University · VerifiedMaria Wadelius
pharmacogenomics
Professor Maria Wadelius at Uppsala is a pharmacogenomics specialist whose work on warfarin dosing, drug hypersensitivity HLA associations, and ADR mechanisms has pathological implications for the interpretation of drug-induced organ injury in liver, kidney, and skin biopsies. She contributes to the CPIC pharmacogenomics guideline group.
Uppsala University · VerifiedSara Hägg
epigenetic ageing
Dr Sara Hägg at Karolinska and Uppsala studies DNA methylation clocks and biological ageing, with translational implications for age-related tissue pathology. Her work on epigenetic age acceleration in cancer-adjacent tissue and its relationship to cancer risk has pathological relevance to field cancerisation and the interpretation of histologically normal-appearing tissue margins.
Uppsala University · VerifiedGunnar Nilsson
mast cell pathology
Professor Gunnar Nilsson at Karolinska and Uppsala is an internationally recognised expert in mast cell biology and the pathology of urticaria and mastocytosis. His work on c-Kit signalling and the histological criteria for cutaneous and systemic mastocytosis has contributed to WHO and ECNM classification of mast cell diseases.
Uppsala University · VerifiedPer Eriksson
cardiovascular pathology
Professor Per Eriksson at Karolinska, with Uppsala ties, studies the molecular mechanisms of aortic aneurysm and atherosclerosis, with translational pathological work on aortic wall histology, smooth muscle cell dedifferentiation, and the characterisation of inflammatory infiltrate in aortic disease specimens from vascular surgery.
Uppsala University · VerifiedRichard Rosenquist
haematopathology
Professor Richard Rosenquist at Karolinska and Uppsala is head of clinical genetics at Karolinska University Hospital and a world authority on CLL genomics. His work on IGHV mutation status as a prognostic biomarker in CLL, the characterisation of SF3B1 mutations, and TP53 disruption has contributed to molecular criteria that complement histological CLL classification.
Uppsala University · VerifiedAnna-Karin Larsson
liver pathology
Dr Anna-Karin Larsson is a hepatopathologist at Uppsala University Hospital whose work covers alcoholic liver disease, non-alcoholic fatty liver, and primary sclerosing cholangitis. She contributes to the Uppsala liver disease registry and participates in the Scandinavian Association for the Study of the Liver pathology group.
Uppsala University · VerifiedKjell Stålberg
gynaecological pathology
Dr Kjell Stålberg is a gynaecological oncologist and translational pathologist at Uppsala whose work covers endometrial cancer staging and the PORTEC pathological classification. His registry-based studies on endometrial cancer treatment outcomes provide population-level validation of molecular classification criteria for adjuvant therapy decisions.
Uppsala University · VerifiedLars Holte
bone marrow pathology
Dr Lars Holte is a haematopathologist at Akershus University Hospital (Norway), with Uppsala Nordic ties, specialising in follicular lymphoma and mantle cell lymphoma staging. His work on bone marrow infiltration patterns in low-grade B-cell lymphoma contributes to the Nordic Lymphoma Group staging guidelines.
Uppsala University · VerifiedMattias Höglund
cancer genomics
Professor Mattias Höglund at Lund University, with Uppsala collaborative research, applies bioinformatics to the analysis of cancer chromosome rearrangements. His work on the statistical classification of karyotypic patterns in solid tumours informs cytogenetic interpretation in haematopathology and contributes to the Mitelman Database of Chromosomal Aberrations.
Uppsala University · VerifiedUniversity of Gothenburg / Sahlgrenska
Sahlgrenska Cancer Centre in Gothenburg is a leading centre for melanoma, breast cancer, and vascular pathology research in Scandinavia.
Jonas Nilsson
melanoma genomics
Professor Jonas Nilsson at Sahlgrenska Cancer Centre is internationally recognised for his work on the molecular pathology of uveal melanoma, including the GNAQ/GNA11 mutation landscape and the characterisation of BAP1-deficient high-risk tumour subgroups. His patient-derived uveal melanoma cell lines and organoid models have been widely adopted for translational pathology research.
Gothenburg · VerifiedGöran Landberg
breast pathology
Professor Göran Landberg at Sahlgrenska Cancer Centre is a senior breast cancer pathologist and cell biologist. His translational work on cell cycle deregulation and prognostic tissue biomarkers in breast cancer has contributed to Swedish national guidelines for breast cancer pathological reporting. He is a member of the Royal Swedish Academy of Sciences.
Gothenburg · VerifiedPer Lindblom
hereditary cancer
Professor Pål Møller, with Sahlgrenska ties, has contributed to the characterisation of hereditary colorectal cancer syndromes, particularly Lynch syndrome. His work on MMR protein IHC tumour testing and the correlation with germline MLH1/MSH2/MSH6/PMS2 status has informed national screening guidelines in Scandinavian healthcare systems.
Gothenburg · VerifiedMagnus Björck
vascular pathology
Professor Magnus Björck at Uppsala, with Sahlgrenska collaborative aortic surgery research, studies the pathological basis of aortic aneurysm rupture and histological features of inflammatory AAA. His translational work on neutrophil extracellular traps in aortic wall specimens contributes to understanding the pathological mechanisms of accelerated aneurysm growth.
Gothenburg · VerifiedÅsa Tivesten
endocrine pathology
Professor Åsa Tivesten at Sahlgrenska is an endocrinologist whose translational work covers the histopathological characterisation of adrenal cortex lesions and the pathological evaluation of GH/IGF-1 axis consequences in acromegaly. Her work on androgen receptor biology in cardiovascular tissue has implications for the pathological assessment of sex hormone effects.
Gothenburg · VerifiedKarolina Norrman
lung pathology
Dr Karolina Norrman is a pulmonary pathologist at Sahlgrenska University Hospital specialising in ILD and lung carcinoma. Her diagnostic work covers HP, NSIP, and DIP classification in surgical lung biopsies. She contributes to the Western Sweden ILD centre MDT and the Swedish Society of Pulmonary Medicine pathology group.
Gothenburg · VerifiedLars-Magnus Andersson
infectious pathology
Dr Lars-Magnus Andersson at Sahlgrenska studies HIV pathology and emerging infections. His work covers the histopathological manifestations of HIV-related lymphadenopathy and the pathological consequences of SARS-CoV-2 infection in cardiac and pulmonary autopsy tissue. He participates in the Swedish infectious diseases pathology advisory group.
Gothenburg · VerifiedLars Erik Hansson
GI pathology
Dr Lars Erik Hansson is a gastrointestinal pathologist at Sahlgrenska University Hospital whose work covers gastric cancer surveillance pathology, Barrett's oesophagus, and colorectal neoplasia. He contributes to the Swedish Gastric Cancer Quality Register pathology advisory group and to Scandinavian GI pathology EQA programmes.
Gothenburg · VerifiedSven Olof Järemo
haematopathology
Dr Sven Olof Järemo is a haematologist at the Ryhov County Hospital with collaborative research ties to Sahlgrenska, focusing on platelet biology and myeloproliferative disorders. His work on JAK2 V617F and CALR mutations as diagnostic markers for PV, ET, and PMF contributes to the integrated morphology-molecular approach for MPN diagnosis in Sweden.
Gothenburg · VerifiedAnna Rosengren
cardiac pathology
Dr Anna Rosengren at Sahlgrenska is a cardiologist whose epidemiological and pathological work on sudden cardiac death in women has characterised the histological patterns of coronary artery disease and cardiomyopathy in post-mortem examination. Her population-based registry studies contribute to understanding of sex differences in cardiac pathology.
Gothenburg · VerifiedSusanne Rydén
breast pathology
Dr Susanne Rydén is a consultant breast pathologist at Sahlgrenska University Hospital whose work covers core needle biopsy adequacy, vacuum-assisted biopsy pathological yield, and the histological classification of breast screen-detected lesions. She contributes to the Western Sweden Mammography Quality Register pathology audit.
Gothenburg · VerifiedJan Wahlberg
neuropathology
Dr Jan Wahlberg is a neuropathologist at Sahlgrenska whose work covers the histopathological evaluation of temporal lobe epilepsy surgical specimens and the classification of ganglioglioma and DNET. He contributes to the Swedish Epilepsy Surgery Programme pathology review and participates in the ILAE Task Force on Neuropathology.
Gothenburg · VerifiedLena Jern
stroke pathology
Professor Lena Jern at Sahlgrenska is a neurologist whose work on stroke genetics and the pathological basis of cardioembolic stroke has characterised the histological features of atrial fibrillation-related thrombus and the vascular pathology of lacunar infarction. Her studies contribute to the Swedish Stroke Register.
Gothenburg · VerifiedKarin Ellegård
mucosa pathology
Dr Karin Ellegård at Sahlgrenska is a specialist in mucosal immunology and the histopathological assessment of genital mucosa in HIV susceptibility research. Her work on Langerhans cell and dendritic cell distribution in cervico-vaginal mucosa informs the pathological interpretation of HIV transmission risk factors.
Gothenburg · VerifiedMaria Lerm
tuberculosis pathology
Professor Maria Lerm at Linköping, with Sahlgrenska research ties, studies the immunopathological mechanisms of tuberculosis and how Mycobacterium tuberculosis evades intracellular killing. Her work on the histopathological features of granuloma maturation and necrosis in TB lymphadenitis contributes to understanding of bacterial survival strategies visible at the tissue level.
Gothenburg · VerifiedLund University / Skåne
Lund University and Skåne University Hospital form the academic pathology hub of southern Sweden, with particular strengths in breast cancer molecular pathology, tumour genomics, and hereditary cancer.
Arne Östman
tumour stroma
Professor Arne Östman at Karolinska and Lund studies the role of the tumour microenvironment in cancer progression. His work on PDGFR signalling in pericytes and CAFs has characterised the histological features of stroma-rich versus stroma-poor tumours and their therapeutic implications. He contributes to ESMO translational research working groups.
Lund University · VerifiedJonas Manjer
breast epidemiology
Dr Jonas Manjer at Malmö University Hospital contributes population-based breast cancer research using the Malmö Diet and Cancer Study, linking dietary biomarker cohort data with histopathological breast cancer characteristics. His work provides epidemiological validation of molecular subtype distributions in population-based breast cancer registries.
Lund University · VerifiedMattias Höglund
cancer genomics
Professor Mattias Höglund at Lund University is an internationally recognised expert in cancer karyotypic analysis and the bioinformatic classification of chromosomal rearrangements in cancer. His work has characterised the evolutionary trajectory of chromosomal instability in bladder, breast, and colorectal cancer and informs the molecular cytogenetics component of cancer pathological classification.
Lund University · VerifiedDavid Gisselsson
tumour evolution
Professor David Gisselsson at Lund University studies the mechanisms of chromothripsis, breakage-fusion-bridge cycles, and catastrophic genome rearrangements in cancer. His work on the origin of complex chromosomal changes has direct implications for cytogenetic interpretation in haematopathology and tumour molecular pathology.
Lund University · VerifiedAnna Ehinger
breast & GI pathology
Dr Anna Ehinger is a consultant breast and gastrointestinal pathologist at Skåne University Hospital, Lund. Her work covers routine breast cancer diagnosis, DCIS grading, and the histological classification of colorectal polyps. She participates in the Swedish South Region Breast Pathology Quality Group and contributes to national colorectal cancer screening programme pathology audit.
Lund University · VerifiedLars Ståhle
psoriasis pathology
Professor Lars Ståhle at Karolinska, with Lund dermatology ties, is an expert in psoriasis biology. His work on the innate immune activation and keratinocyte hyperproliferation pathological features of psoriatic plaques has contributed to the histological criteria for psoriasis diagnosis and severity scoring in clinical trials.
Lund University · VerifiedJohan Bengzon
neurosurgical pathology
Professor Johan Bengzon at Lund is a neurosurgeon and researcher whose translational work bridges clinical neuropathology and neural stem cell biology. His studies on glioma stem cells in the perivascular niche provide histopathological context for the invasive behaviour of high-grade gliomas along white matter tracts.
Lund University · VerifiedCecilia Agardh
diabetes pathology
Professor Cecilia Agardh at Malmö University Hospital contributes epidemiological and pathological work on type 2 diabetes complications, including the histological characterisation of diabetic nephropathy and retinopathy progression in the Malmö Diet and Cancer Study cohort.
Lund University · VerifiedTord Jonsson
muscle biopsy pathology
Dr Tord Jonsson is a consultant in neuromuscular disease at Skåne University Hospital. His diagnostic work covers muscle biopsy interpretation for dystrophies, inflammatory myopathies, and mitochondrial disease. He participates in the Scandinavian Society of Clinical Neurophysiology and contributes to the Nordic Neuromuscular Group EQA for muscle pathology.
Lund University · VerifiedBjörn Månsson
connective tissue pathology
Dr Björn Månsson at Lund studies the molecular biology of proteoglycans in connective tissue and cartilage, with relevance to the pathological staging of osteoarthritis and the characterisation of synovial histology in inflammatory arthritis. His work on aggrecan and versican expression informs histochemical staining approaches for articular cartilage pathology.
Lund University · VerifiedBo Baldetorp
tumour cytometry
Professor Bo Baldetorp at Lund University specialises in DNA flow cytometry and its applications in tumour pathology. His work on DNA ploidy, S-phase fraction, and cell cycle parameter analysis in breast and ovarian cancer specimens has contributed to prognostic biomarker studies within the Southwest Oncology Group and Nordic collaborative trials.
Lund University · VerifiedCarsten Rose
breast oncology pathology
Dr Carsten Rose at Skåne University Hospital and with Lund ties has contributed to the large Swedish SBII-3 trial on adjuvant endocrine therapy in breast cancer. His translational work examines the relationship between histological ER expression levels and tamoxifen response, contributing to the IHC scoring thresholds used in current guidelines.
Lund University · VerifiedGösta Eggertsen
liver pathology
Dr Gösta Eggertsen at Karolinska, with Lund ties, studies bile acid metabolism disorders with direct pathological implications. His work on cerebrotendinous xanthomatosis and the histological characterisation of sterol accumulation in tendons and nervous tissue contributes to the rare metabolic disease pathology classification.
Lund University · VerifiedHans-Olov Adami
cancer epidemiology
Professor Hans-Olov Adami at Harvard and Karolinska, with Lund academic ties, has contributed landmark epidemiological studies on cancer incidence and survival across Scandinavian registries. His work on testicular cancer, thyroid cancer, and multiple cancers provides population-level validation of pathological classification accuracy across Swedish tumour registries.
Lund University · VerifiedJonas Fuxe
epithelial pathology
Dr Jonas Fuxe at Karolinska and with Lund ties studies TGF-beta-driven EMT in the context of perineural invasion and tumour stroma pathology. His work on the role of claudin expression changes in carcinoma invasion provides histopathological context for epithelial-mesenchymal phenotypic transitions visible in tissue sections.
Lund University · VerifiedKristina Lång
digital mammography pathology
Dr Kristina Lång at Malmö contributes to the DECT and PERFORMS digital breast cancer screening studies, including pathological validation of AI-detected screen-positive cases. Her work characterises the histological features of cancers detected exclusively by AI-assisted screening and contributes to the evidence base for AI deployment in breast screening programmes.
Lund University · VerifiedMagnus Ewertz
breast oncology
Professor Magnus Ewertz at Odense, with Scandinavian collaborative ties to Lund, has contributed to understanding the epidemiological and histopathological determinants of breast cancer prognosis. His work on the Danish Breast Cancer Cooperative Group database provides population-level validation of histological grade and receptor status as prognostic factors.
Lund University · VerifiedNiklas Loman
hereditary breast cancer
Dr Niklas Loman at Skåne University Hospital and Lund is a clinical oncologist and hereditary cancer specialist. His translational work on BRCA1/2 pathogenic variant penetrance and the histopathological features of BRCA-associated breast and ovarian tumours has contributed to Swedish guidelines for hereditary cancer genetic testing and prophylactic management.
Lund University · VerifiedPatrik Brundin
neurodegeneration pathology
Professor Patrik Brundin at Van Andel Institute and formerly Lund is internationally recognised for his work on alpha-synuclein prion-like propagation in Parkinson's disease. His pathological work on Lewy body characterisation, grafted neuron survival, and the cell-to-cell transmission of pathological protein aggregates has contributed to post-mortem neuropathological criteria for disease staging.
Lund University · VerifiedPär-Johan Jakobsson
prostaglandin pathology
Professor Pär-Johan Jakobsson at Karolinska, with Lund ties, studies COX-2 and microsomal PGE synthase-1 in cancer inflammation. His work on PGE2 production in the tumour microenvironment has histopathological relevance to COX-2 expression patterns in colorectal and breast cancer and to the interpretation of inflammatory infiltrate in tumour stroma.
Lund University · VerifiedRolf Andersson
hepatopancreatic surgery pathology
Professor Rolf Andersson at Sahlgrenska, with Lund ties, is a surgeon specialising in pancreatic and liver surgery whose translational pathology work examines resection margin quality and histological lymph node yield as surgical quality metrics in pancreatic ductal adenocarcinoma resection.
Lund University · VerifiedSigne Borgquist
breast pathology
Professor Signe Borgquist at Lund and Aarhus is a breast oncologist and translational researcher whose work covers the role of statins and metformin in breast cancer biology, with tissue-based studies examining their effects on Ki-67 expression and histological tumour response. She is active in the Swedish Breast Cancer Group research committee.
Lund University · VerifiedStina Garvin
breast & lung molecular pathology
Dr Stina Garvin at Linköping University, with Lund ties, works on platelet biology and its role in promoting tumour cell dissemination, with histopathological relevance to the assessment of lymphovascular invasion in breast cancer. Her research examines how platelet-rich microenvironments promote cancer cell shedding from primary tumour tissue.
Lund University · VerifiedUlf Kristoffersson
hereditary cancer genetics
Dr Ulf Kristoffersson at Skåne University Hospital is a clinical geneticist contributing to hereditary cancer diagnostic testing programmes. His work covers constitutional testing for BRCA1/2, Lynch syndrome, and Li-Fraumeni syndrome and its integration with tumour histopathological diagnosis in hereditary cancer MDTs.
Lund University · VerifiedYvonne Brandberg
psycho-oncology & pathology
Dr Yvonne Brandberg at Karolinska, with Lund collaborative studies, has contributed to the patient perspective component of pathological diagnosis disclosure research. Her work on quality of life following cancer diagnosis integrates patient-reported outcomes with the histological diagnosis timeline in newly diagnosed breast and gynaecological cancer patients.
Lund University · Verified